How rooting around in the dirt landed an East Bay startup an $80M deal


It is the second drug-target deal disclosed by the four-year-old UC Berkeley spinout in the past five months.

Previous The Punch List: Mayor Andrew Ginther shares Columbus' affordable housing plans
Next Prospect Medical says it will lose $2M a month if Delaware County Memorial Hospital injunction isn't lifted